Pfizer
George Galanis has extensive work experience in supply chain management and operations. George began their career at Merck & Co. as a Supply Chain Analyst, where they assisted in coordinating product distribution and developing solutions to improve supply chain operations. George then joined UnitedHealth Group, where they held various roles, including Supply Chain Manager, Senior Supply Chain Manager, Director of Supply Chain Management, Senior Director of Supply Chain Management, and Vice President of Supply Chain Management. In these positions, they focused on developing and implementing strategic plans, optimizing efficiency and productivity, and overseeing major project implementations. George currently works at Pfizer as the Senior Vice President of Operations, responsible for developing strategic plans, overseeing operational departments, and setting comprehensive goals for performance and growth.
George Galanis earned a Bachelor's degree in Economics from Harvard University between 1981 and 1985. George then went on to pursue a Master of Business Administration (MBA) degree in Business Administration, Management and Operations from Harvard University from 1991 to 1993.
Pfizer
605 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.